Dihydropteridine Reductase Activity and Neopterin Levels in Leukemias and Lymphomas: Is There Any Correlation between These Two Parameters?

References

• Müller MM., Curtius H., Herold M., Huber C. Neopterin in clinical practice. Clin Chim Acta 1991; 201: 1–16
   PubMed Web of Science ®Google Scholar
• Backman Ringdén, Bjöjrkhem I. Monitoring serum neopterin levels in renal transplant recipients: increased values during impaired renal function and cytome-galovirus infection. Nephron 1987; 46: 319–322
   PubMedGoogle Scholar
• Reibnegger G., Auhuber I., Fuchs D., Hausen A., Judmaier G., Prior C., Werner E. R., Wachter H. Urinary neopterin levels in acute viral hepatitis. Hepatology 1988; 8: 771–774
   PubMed Web of Science ®Google Scholar
• Bogner J. R., Matuschke A., Heinrich B., Eberle E., Goebel F. D. Serum neopterin levels as predictors of AIDS. Klin Wochenschr 1988; 66: 1015–1018
   PubMedGoogle Scholar
• Reibnegger G., Boonpucknavig V., Fuchs D., Hausen A., Schmutzhard E., Wachter H. Urinary neopterin is elevated in patients with malaria. Trans R Trop Med Hyg 1984; 78: 545–546
   PubMed Web of Science ®Google Scholar
• Hagihara M., Nagatsu T., Ohhashi M., Miura T. Concentrations of neopterin and biopterin in serum from patients with rheumatoid arthritis or systemic lupus erytham-atosus and in synovial fluid from patients with rheumatoid or osteoarthritis. Clin Chem 1990; 36: 705–706
   PubMed Web of Science ®Google Scholar
• Huber C., Batchelor J. R., Fuchs D., Hausen A., Lang A., Niedenvieser D., Reibnegger G., Swetly P., Troppmair J., Wachter H. Immune response associated production of neopterin release from macrophages primarily under control of interferon gamma. J Exp Med 1984; 160: 310–316
   PubMed Web of Science ®Google Scholar
• Werner E. R., Wemer-Felmayer G., Wachter H. Tet-rahydrobiopterin and cytokines. Proc Soc Exp Biol Med 1993; 203: 1–12
   PubMed Web of Science ®Google Scholar
• Abate G., Comella P., Marfella Santelli G., Nitsch F., Fiore M., Pema M. Prognostic relevance of urinary neopterin in non-Hodgkin's lymphomas. Cancer 1989; 63: 484–489
   PubMed Web of Science ®Google Scholar
• Hausen A., Fuchs D., Grönewald K., Huber H., König K., Wachter H. Urinary neopterine as marker of neopla-sias. Clin Chim Acta 1981; 117: 297–305
   PubMed Web of Science ®Google Scholar
• Kuzmits R., Ludwig H., Legenstein E., Szekeresz T., Kratzik C., Hofbauer J. Neopterin as tumor marker serum and urinary neopterin concentrations in malignant disease. J Clin Chem Clin Biochim. 1986; 24: 119–124
   PubMedGoogle Scholar
• Boccadoro M., Battaglio S., Omedé P., Palumbo A. P., Fusaro A., Frieri R., Gallone G., Polloni R., Mosso R., DeFilippi P. G., Pileri A. Increased serum neopterin as concentration as indicator of disease severity and poor survival in multiple myloma. Eur J Haematol 1991; 47: 305–309
   PubMed Web of Science ®Google Scholar
• Whiteley J. M., Varughes K. I., Xuong N. H., Mathews D. A., Grimshaw C. E. Dihydropteridine reductase. Pteridines 1993; 4: 159–173
   Google Scholar
• Kaufman S. The structure of phenylalanine hydroxy-lation cofactor. Proc Natl Acad Sci USA 1963; 50: 1085–1093
   PubMed Web of Science ®Google Scholar
• Shiman R., Akino M., Kaufman S. Solubilization and partial purification of tyrosine hydroxylase from adrenal medulla. J Biol Chem 1971; 246: 1330–1340
   PubMed Web of Science ®Google Scholar
• Friedman P. A., Kappelman H., Kaufman S. Partial purification and characterisation of tryptophan hydroxylase from rabbit hindbrain. J Biol Chem 1972; 247: 4165–4173
   PubMed Web of Science ®Google Scholar
• Tayek M. A., Marletta M. A. Macrophage oxidation of L-arginine to nitric oxide, nitrite and nitrate. J Biol Chem 1989; 264: 19654–19658
   PubMed Web of Science ®Google Scholar
• Tietz A., Lindberg M., Kennedy E. P. A new pteri-dine requring enzyme system for oxidation of glyceryl ethers. J Biol Chem 1964; 239: 4081–4090
   PubMed Web of Science ®Google Scholar
• Mura P., Morlier J. P., Bariere M., Bredon P., Papet Y., Chameaud J. Increased biopterin production in rats with tumor induced by radon inhalation and benzonapthofla-vone administration. Cuncer Letters 1990; 54: 57–60
   PubMed Web of Science ®Google Scholar
• Dhondt J. L., Bonneterre J., Farriaux J. P., Lefebvre J., Demaille A. Dihydropteridine reductase activity in breast cancer, preliminary report. Biomedicine 1981; 35: 58–60
   PubMedGoogle Scholar
• Zeitler H. J., Andondonskaja-Renz B. Evaluation of pteridines in patients with different tumors. Cancer Detect and Prev 1987; 10: 71–79
   PubMedGoogle Scholar
• Hoffman R., Benz E. J., Sanford J., Shattil B. F., Cohen H. J. Hematology. Basic principles and practice. Churchill Livingstone, New York 1991
   Google Scholar
• Haskell C. M. Cancer treatment, 4th edn. WB Saunders Company, Philadelphia 1995
   Google Scholar
• Bauer J. D. Clinical laboratory methods, 9 edn. The C. V. Mosby Company., London 1982; 489–490
   Google Scholar
• Altindaĝ Z., Şahin G., Akpck G., Koç Y., Işimer A., Kansu E. Urinary neopterin levels as an indicator of disease activation in Behçet's disease. Pteridines 1995; 6: 79–83
   Web of Science ®Google Scholar
• Arai N., Narisawa K., Hayakawa H., Tada K. Hyperphenylalaninemia due to dihydropteridine ductase deficiency: diagnosis by enzyme assays on dried blood spots. Pediatrics 1982; 70: 426–430
   PubMed Web of Science ®Google Scholar
• Şimşek H., Kadayifçi A., Altindaĝ Z. Z., Şahin G. High urinary neopterin levels in familial mediterranean fever. Clin Exp Rheumatol 1996; 14: 224–225
   PubMed Web of Science ®Google Scholar
• Altindaĝ Z. Z., Şahin G., Inanici F., Hasçelik Z. Urinary neopterin excretion and dihydmpteridine reductase activity in rheumatoid arthritis. Rheumatol Int 1998; 18: 107–111
   PubMed Web of Science ®Google Scholar
• Denz H., Fuchs D., Huber H., Nachbaur D., Reibnegger G., Thaler J., Werner E. R., Wachter H. Correlation between neopterin. interferon-gamma and haemoglobin in patients with disorders. Eur J Haematol 1990; 44: 186–199
   PubMed Web of Science ®Google Scholar
• Fuchs D., Milstien S., Kramer A., Reibnegger G., Werner E. R., Goedert J. J., Kaufman S, Wachter H. Urinary neopterin concentrations vs. total neopterins for clinical utility. Clin Chem 1989; 35: 2305–2307
   PubMed Web of Science ®Google Scholar
• Fuchs D., Reibnegger G., Werner E. R., Wachter H. Increased 7.8-dihydmneopterin and reduced methyl-group metabolism in HIV-1 infection. Lancet 1990; 335: 1167
   PubMed Web of Science ®Google Scholar
• Ochs J. J., Pui C. H., Mason C., Bowman W. P., Abromow-Itch M., Shone J. V. Seizures in childhood lympho-blastic leukemia patients. Lancet 1984; 2: 1422–1424
   PubMed Web of Science ®Google Scholar
• Iwagaki H., Hizuta A., Uomoto M., Takeuchi Y., Saito S., Tanaka N. Cancer cachexia and depressive states: a neuro-endocrine-immunological disease. Acta Med Okayama 1997; 51: 233–236
   PubMed Web of Science ®Google Scholar
• Blau N., Curtius H. C., Kierat L. Hyperphenylalaninemia caused by dihydropteridine reductase deficiency in children receiving chemotherapy for acute lymphoblastic leukemia. J Pediatr 1989; 115: 661–663
   PubMed Web of Science ®Google Scholar
• Millot F., Dhondt J. L., Mazingue F., Mechinaud F., Ingrand P., Guilhot F. Changes of cerebral biopterin and biogenic amine metabolism in leukemic children receiving 5 g/m2 intravenous methotrexate. Pediatric Research 1995; 37: 151–154
   PubMed Web of Science ®Google Scholar